Medical Malpractice Attorneys of Toledo, Williams DeClark Tuschman, are
accepting cases that involve the testosterone replacement treatment, AndroGel.
Low testosterone is a simple fact of life. As we age, testosterone levels
in the human body lower. Due to modern technology, it is now possible
to give our bodies a boost to help raise testosterone levels. As consumers,
we put our faith and trust in the drug companies that help us with a better
way of living. We expect them to be honest and upfront with side effects
so that we can make and educated choice. But that always isn’t the
case with low testosterone replacement therapy.
Most recently, multiple lawsuits have been filed against Abbott Laboratories
Inc. and AbbVie Inc. In each case it was alleged that the companies downplayed
the risks of strokes and heart attacks that are associated with testosterone
replace treatment AndorGel.
It’s alleged in the lawsuits that Abbott Laboratories Inc. and AbbVie
Inc. have engaged in extensive advertising campaigns about Low Testosterone
(Low T). Their message to consumers was that the natural effects of aging
in men, such as listlessness and weight gain, were actually symptoms of
the condition that could be treated with their products. The complaints
do not see that way as they allege:
“What consumers received, however, were not safe drugs, but a product
which causes life-threatening problems, including strokes and heart attacks.”
It has also come to light that just days before the lawsuits were filed
the U.S. Food and Drug Administration (FDA) began to investigate the treatment.
The FDA was investigating possible increased risk of heart attack, stroke
and death in men who were using testosterone replacement therapies like AndroGel.
The FDA pointed to two recent research articles that found elevated cardiovascular
risks in men using testosterone replacement products. The Plantiffs referenced
the same articles in their cases.
Based on one of the published articles, it was alleged that Abbott and
AbbVie “purposefully downplayed, understated and outright ignored”
AndroGel’s risks in their marketing campaign. Three of the plaintiffs
suffered heart attacks after taking AndroGel, one suffered a stroke, and
another suffered a so-called mini stroke, according to the complaints.
The Plaintiffs are bringing claims for:
- Failure to warn;
- Breach of implied warranty;
- Breach of express warranty;
- Fraud; and
- Negligent misrepresentation
Before you begin low testosterone replacement therapy, research the drug
If you or someone you know has been affected by low testosterone replacement
contact Toledo’s Medical Malpractice Attorneys, William DeClark Tuschman
via our web contact form or on our office phone at 419-241-7700. WDT law
will be more than happy to answer any questions you may have and prepare
you for the necessary course of action to take.